Clinical Development Statistical Strategy
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.

Algoria Biometrics
Find support for developing a scientific application, reviewing clinical programming, or automating analyses and reports. You can also explore study design, biostatistical analysis, data quality and other services for your project.
An analysis plan with explicit decisions and assumptions; datasets and tables with code and QC; or a scientific tool with tests and handover instructions. Deliverables are defined around your question and available materials.
A defined project, part-time support or integration into your team. We agree allocation, responsibilities and review criteria before work begins.
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.
SAP authorship and updates for clinical studies: endpoints, estimands, populations, methods, sensitivity analyses and output specifications.
Statistical study design, sample size and power analysis for biomedical research, with documented scenarios, simulation, sampling and randomisation planning.
Data and assumption assessment for trial feasibility: eligibility, populations, follow-up and enrolment scenarios subject to validation.
Feasibility assessment for demand forecasting, segmentation and statistical process control: data requirements, validation and analytical scope for businesses.
SDTM and ADaM preparation, transformation and review: mapping, derivations, metadata, QC and traceability between source data, SAP and outputs.
Clinical trial tables, listings and figures with production and QC in SAS and R: shells, derivations, safety, efficacy, interim and final reporting.
Modernise SAS macros and R workflows with reusable functions, TLF templates, QC automation, documentation and equivalence checks.
Clinical and biomarker data integration with R, Python, SQL and Databricks: data models, pipelines, QC, lineage and analytical applications.
Build, recover and maintain R/Shiny applications with source code, tests and handover. Scope and support agreed for each project.
Research database cleaning and coding, data dictionaries and case report form design with traceable validation rules and analysis-ready transformations.
Technical review of clinical programming deliverables: prioritised findings, acceptance criteria and remediation recommendations.
Interim analysis and DSMB/DMC statistical packages: data cuts, TLF programming, QC and traceability under defined access and review rules.
Senior review of specifications, SDTM/ADaM, TLFs and QC evidence, with technical coordination and an agreed time allocation.
Reproducible statistical analysis for clinical studies, cohorts and registries, including longitudinal models, survival, missing data and scientific reporting.
Repeated-measures, mixed-effects and time-to-event analysis for clinical studies: covariates, censoring, missingness and sensitivity.
Observational, post-marketing, pragmatic and before-after study analysis: adherence, outcomes, covariate adjustment and sensitivity.
Predictive modelling, responder profiling and clinical stratification: regression, classification, clustering, validation, discrimination and calibration.
Statistical support for clinical technologies, procedures, PROMs and repeated symptoms: design, outcomes, comparison and interpretation.
Analysis and reporting for vaccine studies and immunogenicity data: SAPs, clinical/laboratory integration, longitudinal response and QC.
Statistical support for clinical laboratory assays: variability, reproducibility, stability, validation design and evaluation criteria.
We assess the question, technology, processing stage and specific expertise needed before proposing an analysis. Scope identifies the input data, methods, and who will perform and review the work.
Statistical review of biomedical manuscripts, methods, results and tables, with focused support for journal reviewer responses and analysis corrections.
Statistical support for biomedical PhD research: study design, data preparation, reproducible analysis and interpretation with the research team.
Statistical and methodological review of research proposals: objectives, endpoints, sample size, feasibility and analysis plans for biomedical R&D.
Tailored biostatistics, R and reproducible analysis training for researchers and biomedical teams, with practical workshops matched to objectives and experience.
For an urgent decision or a bounded review, these engagements provide a focused starting point with defined inputs and deliverables.
We review agreed materials to identify inconsistencies, prioritise findings and propose a remediation plan. You receive an issue log and outstanding decisions; subsequent corrections are scoped separately.
Find evidence and traceability gaps before CSR, audit, due diligence or submission.
Identify statistical, estimand and analysis risks before finalisation or regulatory review.
We assess whether the data and rules for population, dates and follow-up support a specific question. You receive findings, limitations and recommendations; cohort definition and analysis are specified in scope.
We assess the question, technology, processing stage and specific expertise needed before proposing an analysis. Scope identifies the input data, methods, and who will perform and review the work.
For teams that update data and need to regenerate tables, figures or reports consistently. We turn agreed steps into a reproducible workflow, with parameters, checks and a record of each run.
Tell us about the objective, study stage and deadline. We review the need and availability; we then define the scope with you and prepare a proposal with deliverables, timing and fees.
Do not email patient, clinical or confidential study data. Access and the working environment are agreed before materials are shared.
Discuss your project